Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4896daaa94fb384d91042bf0e47e2f6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 |
filingDate |
2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d28341372711955cb07a17340d5a687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fecadddc956901c8309457b4f052fd3 |
publicationDate |
2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7144922-B2 |
titleOfInvention |
Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as AIDS |
abstract |
A method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as acquired immunodeficiency syndrome (AIDS) includes a glycol derivative. More specifically, the glycol derivative includes diethylene glycol dibenzoate. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241410-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11211826-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022046324-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11742700-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11743841-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11611242-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11178625-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11183886-B2 |
priorityDate |
2002-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |